JP2015534970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015534970A5 JP2015534970A5 JP2015537264A JP2015537264A JP2015534970A5 JP 2015534970 A5 JP2015534970 A5 JP 2015534970A5 JP 2015537264 A JP2015537264 A JP 2015537264A JP 2015537264 A JP2015537264 A JP 2015537264A JP 2015534970 A5 JP2015534970 A5 JP 2015534970A5
- Authority
- JP
- Japan
- Prior art keywords
- multiple myeloma
- cyclodextrin
- sulfoalkyl ether
- group
- substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12188789 | 2012-10-17 | ||
| EP12188789.7 | 2012-10-17 | ||
| PCT/EP2013/071779 WO2014060548A1 (de) | 2012-10-17 | 2013-10-17 | Anthocyanidin-komplex zur behandlung von multiplem myelom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015534970A JP2015534970A (ja) | 2015-12-07 |
| JP2015534970A5 true JP2015534970A5 (https=) | 2016-11-10 |
Family
ID=47115385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015537264A Ceased JP2015534970A (ja) | 2012-10-17 | 2013-10-17 | 多発性骨髄腫の治療のためのアントシアニジン複合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150258202A1 (https=) |
| EP (1) | EP2908829A1 (https=) |
| JP (1) | JP2015534970A (https=) |
| KR (1) | KR20150070303A (https=) |
| CN (1) | CN104780925A (https=) |
| CA (1) | CA2887057A1 (https=) |
| HK (1) | HK1212590A1 (https=) |
| WO (1) | WO2014060548A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014075935A1 (de) * | 2012-11-15 | 2014-05-22 | Sapiotec Gmbh | Delphinidinkomplex als antiphlogistischer oder immunsuppressiver wirkstoff |
| US9949947B2 (en) * | 2012-12-11 | 2018-04-24 | Sapiotec Gmbh | Delphinidin for combating melanoma cells |
| KR102050639B1 (ko) | 2017-11-08 | 2019-11-29 | 경희대학교 산학협력단 | 왕불류행 추출물을 포함하는 암의 예방 및 치료용 조성물 |
| KR101982937B1 (ko) | 2017-11-08 | 2019-05-27 | 경희대학교 산학협력단 | 천궁 추출물을 포함하는 암의 예방 및 치료용 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US6869939B2 (en) * | 2002-05-04 | 2005-03-22 | Cydex, Inc. | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| JP2004238336A (ja) * | 2003-02-07 | 2004-08-26 | Sanei Gen Ffi Inc | 水易溶性包接フラボノイド類の製造方法 |
| US20050013880A1 (en) * | 2003-03-06 | 2005-01-20 | Magnuson Bernadene Ann | Anthocyanin-rich compositions and methods for inhibiting cancer cell growth |
| ES2235642B2 (es) * | 2003-12-18 | 2006-03-01 | Gat Formulation Gmbh | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. |
| WO2009018326A2 (en) * | 2007-07-31 | 2009-02-05 | Limerick Biopharma, Inc. | Soluble pyrone analogs methods and compositions |
| US7635773B2 (en) * | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| CN102892310B (zh) * | 2010-03-13 | 2016-07-06 | 伊斯顿庞德实验室有限公司 | 结合脂肪的组合物 |
| AU2010366535A1 (en) * | 2010-12-31 | 2013-07-11 | Eastpond Laboratories Limited | Cellular hydration compositions containing cyclodextrins |
| JP6193970B2 (ja) * | 2012-03-30 | 2017-09-06 | ザピオテック・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＳＡＰＩＯＴＥＣ ＧｍｂＨ | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対するデルフィニジンの使用 |
| CA2869056C (en) * | 2012-03-30 | 2020-02-25 | Sapiotec Gmbh | Anthocyanidin complex |
-
2013
- 2013-10-17 CN CN201380053224.2A patent/CN104780925A/zh active Pending
- 2013-10-17 HK HK16100459.6A patent/HK1212590A1/zh unknown
- 2013-10-17 JP JP2015537264A patent/JP2015534970A/ja not_active Ceased
- 2013-10-17 CA CA2887057A patent/CA2887057A1/en not_active Abandoned
- 2013-10-17 WO PCT/EP2013/071779 patent/WO2014060548A1/de not_active Ceased
- 2013-10-17 EP EP13779804.7A patent/EP2908829A1/de not_active Withdrawn
- 2013-10-17 US US14/432,654 patent/US20150258202A1/en not_active Abandoned
- 2013-10-17 KR KR1020157012569A patent/KR20150070303A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vo et al. | Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs | |
| Singh | Impact of product-related factors on immunogenicity of biotherapeutics | |
| Irwin et al. | Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise | |
| EA201792487A1 (ru) | Композиции гидроксипропил-бета-циклодекстринов и способы | |
| JP2015534970A5 (https=) | ||
| MX2013015005A (es) | Microparticulas de dicetopiperazina de alta capacidad. | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| CO6640268A2 (es) | Formas de decodificación oral de bendamustina y su uso terapéutico | |
| PE20110583A1 (es) | Comprimidos de capecitabina de disgregacion rapida | |
| RU2015143475A (ru) | Продукт и способ лечения диареи | |
| JP2015520241A5 (https=) | ||
| CL2016002318A1 (es) | Composición farmacéutica en forma de solución que comprende un portador líquido que comprende agua y entre 20% y 95% de uno o mas alcoholes y citrato de sildenafil disuelto en dicho portador líquido a una concentración de entre 7 y 125 mg/ml; métodos para obtenerla; forma de dosificación oral; forma de dosificación bucal; kits. | |
| JP2015120758A5 (https=) | ||
| MX375187B (es) | Composiciones farmacéuticas secas que comprenden nanopartículas de agente activo ligadas a partículas portadoras. | |
| JP2016503416A5 (https=) | ||
| Koneri et al. | Antiangiogenic and anticancer activity of saponins of Momordica cymbalaria. | |
| JP2017513866A5 (https=) | ||
| CN102675338A (zh) | 微粉化普拉格雷及其药用组合物 | |
| JP2016502984A5 (https=) | ||
| CN103239400B (zh) | 一种伊曲康唑纳米混悬剂及其制备方法 | |
| CN102670532B (zh) | 伊潘立酮药物组合物及其制备方法 | |
| Gholamzadeh et al. | The effect of cyclodextrin mixtures on aqueous solubility of beclomethasone dipropionate | |
| ZHAO et al. | Pharmaceutical Care for One Patient with Chronic Obstructive Pulmonary Disease | |
| CY1126580T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα μιτοτανη για απο του στοματος χορηγηση για χρηση στη θεραπεια καρκινωματος του φλοιου των επιδενεφριδιων και συνδρομου cushing | |
| Youssef et al. | Single-dose pharmacokinetic properties of esomeprazole in children aged 1-11 years with endoscopically proven GERD: a randomized, open-label study |